CR20150665A - Complemento de hierro - Google Patents
Complemento de hierroInfo
- Publication number
- CR20150665A CR20150665A CR20150665A CR20150665A CR20150665A CR 20150665 A CR20150665 A CR 20150665A CR 20150665 A CR20150665 A CR 20150665A CR 20150665 A CR20150665 A CR 20150665A CR 20150665 A CR20150665 A CR 20150665A
- Authority
- CR
- Costa Rica
- Prior art keywords
- iron
- component
- zinc
- chelating
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Abstract
Un sistema de dosis suministrable oralmente comprende (a) hierro en una forma de uno o más compuestos y/o complejos, grado de hierro aceptable fisiológicamente; y (b) un agente para mitigar uno o más efectos adversos gastrointestinales de hierro no absorbido, el agente que comprende uno o tanto el componente de zinc y un componente quelante, el componente de zinc si está presente comprende uno o más compuestos y/o complejos de zinc aceptables fisiológicamente y el componente quelante si está presente comprende un compuesto quelante de hierro formulado para liberación distal al sitio primario de absorción de hierro en el duodeno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361831879P | 2013-06-06 | 2013-06-06 | |
PCT/US2014/039738 WO2014197250A1 (en) | 2013-06-06 | 2014-05-28 | Iron supplement |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20150665A true CR20150665A (es) | 2016-02-24 |
Family
ID=52005976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20150665A CR20150665A (es) | 2013-06-06 | 2015-12-17 | Complemento de hierro |
Country Status (12)
Country | Link |
---|---|
US (2) | US11331287B2 (es) |
EP (1) | EP3003328B1 (es) |
AU (1) | AU2014275307B2 (es) |
BR (1) | BR112015029468A8 (es) |
CA (1) | CA2913413C (es) |
CR (1) | CR20150665A (es) |
ES (1) | ES2895044T3 (es) |
GT (1) | GT201500328A (es) |
MX (1) | MX2015016660A (es) |
PL (1) | PL3003328T3 (es) |
WO (1) | WO2014197250A1 (es) |
ZA (1) | ZA201508363B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3334440T3 (en) | 2015-08-11 | 2021-07-26 | Akeso Biomedical Inc | Biofilm inhibiting compositions enhancing weight gain in livestock |
US10653658B2 (en) | 2015-08-11 | 2020-05-19 | Akeso Biomedical, Inc. | Biofilm inhibiting compositions enhancing weight gain in livestock |
US11083738B2 (en) * | 2017-09-28 | 2021-08-10 | Natals, Inc. | Dietary nutrient compositions |
SG11202003153TA (en) | 2017-10-25 | 2020-05-28 | Chiesi Farm Spa | Delayed release deferiprone tablets and methods of using the same |
US20230321060A1 (en) * | 2022-04-11 | 2023-10-12 | Chiesi Farmaceutici S.P.A. | Modified release pharmaceutical formulations comprising deferiprone |
US20230321061A1 (en) * | 2022-04-11 | 2023-10-12 | Chiesi Farmaceutici S.P.A. | Modified release pharmaceutical formulations comprising deferiprone |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL91047A (en) * | 1989-07-19 | 1993-06-10 | Yissum Res Dev Co | Zinc complexes for the treatment of free radical- induced diseases |
US5536507A (en) * | 1994-06-24 | 1996-07-16 | Bristol-Myers Squibb Company | Colonic drug delivery system |
US5516925A (en) | 1994-08-23 | 1996-05-14 | Albion International, Inc. | Amino acid chelates having improved palatability |
US6521247B1 (en) * | 1999-08-13 | 2003-02-18 | Warner Chilcott Laboratories Ireland Limited | Dual iron containing nutritional supplement |
US7160855B2 (en) | 2002-03-14 | 2007-01-09 | Children's Hospital & Research Center At Oakland | Enhancement of iron chelation therapy |
US20060134227A1 (en) | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
CN1965697A (zh) | 2005-11-15 | 2007-05-23 | 王健柏 | 营养补血保健饮用制品 |
US8007846B2 (en) | 2006-01-18 | 2011-08-30 | Albion International, Inc. | Mixed amino acid/mineral compounds having improved solubility |
TW200843802A (en) * | 2007-02-09 | 2008-11-16 | Drugtech Corp | Compositions for improving gastrointestinal nutrient and drug absorption |
US20090068190A1 (en) * | 2007-08-29 | 2009-03-12 | Drugtech Corporation | Anti-proliferative combinations |
WO2010136839A1 (en) * | 2009-05-29 | 2010-12-02 | Carlo Ghisalberti | Use of deferoxamine and related compounds in targeted delivery forms to treat an inflammatory bowel disease |
CN101744120B (zh) | 2009-12-25 | 2012-04-11 | 河北农业大学 | 乳仔猪微量元素预混料 |
CN102318764B (zh) | 2011-08-30 | 2014-04-02 | 武汉天龙饲料有限公司 | 一种无抗仔猪教槽料及其制备方法 |
CA2849732C (en) | 2011-09-22 | 2019-10-01 | Jonathan Bortz | Buffered upper gi absorption promoter |
-
2014
- 2014-05-28 ES ES14807576T patent/ES2895044T3/es active Active
- 2014-05-28 PL PL14807576T patent/PL3003328T3/pl unknown
- 2014-05-28 MX MX2015016660A patent/MX2015016660A/es active IP Right Grant
- 2014-05-28 EP EP14807576.5A patent/EP3003328B1/en active Active
- 2014-05-28 US US14/288,802 patent/US11331287B2/en active Active
- 2014-05-28 AU AU2014275307A patent/AU2014275307B2/en active Active
- 2014-05-28 CA CA2913413A patent/CA2913413C/en active Active
- 2014-05-28 WO PCT/US2014/039738 patent/WO2014197250A1/en active Application Filing
- 2014-05-28 BR BR112015029468A patent/BR112015029468A8/pt not_active Application Discontinuation
-
2015
- 2015-11-12 ZA ZA2015/08363A patent/ZA201508363B/en unknown
- 2015-11-20 GT GT201500328A patent/GT201500328A/es unknown
- 2015-12-17 CR CR20150665A patent/CR20150665A/es unknown
-
2022
- 2022-04-12 US US17/718,538 patent/US20220233476A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR112015029468A8 (pt) | 2020-03-17 |
EP3003328A4 (en) | 2017-05-03 |
US11331287B2 (en) | 2022-05-17 |
PL3003328T3 (pl) | 2022-01-24 |
GT201500328A (es) | 2017-12-14 |
AU2014275307A1 (en) | 2015-12-10 |
US20220233476A1 (en) | 2022-07-28 |
ZA201508363B (en) | 2017-09-27 |
AU2014275307B2 (en) | 2017-06-15 |
US20140364491A1 (en) | 2014-12-11 |
WO2014197250A1 (en) | 2014-12-11 |
CA2913413C (en) | 2021-11-23 |
EP3003328B1 (en) | 2021-07-28 |
EP3003328A1 (en) | 2016-04-13 |
CA2913413A1 (en) | 2014-12-11 |
ES2895044T3 (es) | 2022-02-17 |
MX2015016660A (es) | 2016-07-26 |
BR112015029468A2 (pt) | 2017-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150665A (es) | Complemento de hierro | |
CL2018000318A1 (es) | Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925) | |
PH12016500072B1 (en) | Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof | |
WO2015095811A3 (en) | Combination therapy with neoantigen vaccine | |
CU20170172A7 (es) | 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos | |
CL2015002164A1 (es) | Formulación combinada de dos compuesos antivirales. | |
BR112015022047A2 (pt) | métodos para tratar câncer de bexiga | |
CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
EP4233889A3 (en) | Activin-actrii antagonists and uses for treating myelodysplastic syndrome | |
HRP20191000T1 (hr) | Spojevi za vezanje nhe3 i metode inhibiranja transporta fosfata | |
UY33446A (es) | Composiciones solidas | |
CL2013000713A1 (es) | Compuestos pirazin-2-cabonil-imino-1,3,8-triaza-espiro-[4.5]-decan-sustituidos, bloqueadores del canal de sodio epitelial (enac); composicion farmaceutica que los incluye; metodo de prevencion o tratamiento; y su uso para tratar una enfermedad o condicion mediada por el bloqueo del canal de sodio epitelial. | |
WO2011113013A3 (en) | Methods and compositions for treating viral or virally-induced conditions | |
GT201400012A (es) | Compuesto inhibidor de la señalizacion de la trayectoria notch | |
BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
PH12015501783B1 (en) | Pharmaceutical compositions for the treatment of helicobacter pylori | |
MX2015010829A (es) | Compuestos terapeuticos y sus usos. | |
ECSP15051434A (es) | Composición farmacéutica de dosis baja | |
CR20150505A (es) | Derivado de dihidropiridazin-3,5-diona | |
AR091351A1 (es) | Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion | |
CL2015002466A1 (es) | Formulaciones de compuestos orgánicos | |
MX2015007940A (es) | Compuestos tricíclicos como inhibidores de cftr. | |
WO2014182789A3 (en) | Radiomitigating pharmaceutical formulations | |
BR122020011180B8 (pt) | formulações injetáveis de compostos de tetraciclina | |
MX2015012318A (es) | Formas de estado solido de un derivado de quinazolina y su uso como un inhibidor de braf. |